SION
Sionna Therapeutics, Inc.
There isn't enough reported data to score SION yet.
SION Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SION's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
SION PE Valuation
SION has no meaningful PE right now: it lost money over the past year.
SION Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect SION's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
SION Earnings Per Share
SION Quarterly Revenue
SION Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$18.7M | -$3.4M |
| Q2 2026 | -$22.2M | -$4.1M |
| Q1 2026 | -$21.8M | -$5.5M |
| Q4 2025 | -$16.8M | -$5M |
| Q3 2025 | -$15.3M | +$2.4M |
| Q2 2025 | -$18.2M | -$8M |
| Q1 2025 | -$16.4M | -$3.2M |
| Q4 2024 | -$11.8M | -$4.2M |
SION has burned cash in almost every quarter: −$80M over the past year, against −$62M the year before.
SION Net Leverage
SION's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SION Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.5 | Oversold |
| Stochastic | 1.8 | Oversold |
SION's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
SION PE vs Healthcare Sector
SION has no meaningful PE right now: it lost money over the past year.
SION Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.14 | 17% below |
| 20 week MA | $17.7 | 81% below |
| 50 week MA | $30.7 | 89% below |
SION is in a downtrend: it's below all three of its weekly moving averages, and 89% below its 50-week average.
SION Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $25.0 | $43.7 | +75% |
| 2026 YTD | $43.7 | $3.43 | -92% |
SION has finished every year since 2025 higher, and it's down 92% so far in 2026.